Cargando…
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
Monoclonal gammopathy of undetermined significance (MGUS) is a benign hematological condition with the potential to progress to malignant conditions including multiple myeloma and Waldenstrom macroglobulinemia. Medications that modify progression risk have yet to be identified. To investigate, we le...
Autores principales: | Ryu, Alexander J., Kumar, Shaji, Dispenzieri, Angela, Kyle, Robert A., Rajkumar, S. Vincent, Kingsley, Thomas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935510/ https://www.ncbi.nlm.nih.gov/pubmed/36797276 http://dx.doi.org/10.1038/s41408-023-00798-7 |
Ejemplares similares
-
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021) -
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement
por: Murray, David, et al.
Publicado: (2019) -
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
por: Kleinstern, Geffen, et al.
Publicado: (2022) -
Cardiovascular Associations With Monoclonal Gammopathy of Undetermined Significance: Real or Coincidental?
por: Kapoor, Prashant, et al.
Publicado: (2022) -
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
por: Ho, Matthew, et al.
Publicado: (2022)